特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

細胞分離の世界市場:2020年~2024年

Cell Separation Market by End-User and Geography - Forecast and Analysis 2020-2024

発行 TechNavio (Infiniti Research Ltd.) 商品コード 626566
出版日 ページ情報 英文 142 Pages
即納可能
価格
本日の銀行送金レート: 1USD=107.17円で換算しております。
細胞分離の世界市場:2020年~2024年 Cell Separation Market by End-User and Geography - Forecast and Analysis 2020-2024
出版日: 2019年11月19日 ページ情報: 英文 142 Pages
概要

世界の細胞分離市場は、研究および臨床応用における細胞分離技術の採用の拡大、癌研究における細胞分離の使用の増加、HIV / AIDSの高い有病率などが成長促進要因となり、予測期間中に17%以上のCAGRで拡大する見込みです。しかし、一貫性のない試薬やその他の補助製品の存在、実験室の職員が直面する曝露リスク、およびサンプル汚染のリスクなどの要因が、予測期間中の細胞分離業界の成長を妨げる可能性があります。

当レポートでは、世界の細胞分離市場について調査分析し、市場規模および成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

  • イントロダクション1
  • イントロダクション2
  • 米ドルの通貨換算レート

第3章 市場状況

  • 市場のエコシステム
  • 市場の特徴
  • 市場セグメンテーション分析

第4章 市場規模

  • 市場の定義
  • 市場規模(2019年)
  • 市場の見通し
  • 市場規模および予測(2019年~2024年)

第5章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争相手の脅威
  • 市況

第6章 市場セグメンテーション:エンドユーザー別

  • 市場セグメンテーション:エンドユーザー別
  • エンドユーザー別比較:市場規模および予測(2019年~2024年)
  • 学術機関および研究所
  • 製薬およびバイオテクノロジー企業
  • 病院および臨床検査室
  • 市場機会:エンドユーザー別

第7章 顧客情勢

第8章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較:市場規模および予測(2019年~2024年)
  • 北米
  • 欧州
  • アジア
  • その他の地域
  • 主要国
  • 市場機会

第9章 意思決定の枠組み

第10章 成長要因と課題

  • 市場成長要因
  • 市場の課題

第11章 市場動向

  • 幹細胞に関連する研究活動の増加
  • オーダーメイド医療への関心の高まり
  • プロモーション活動に焦点

第12章 ベンダー情勢

  • 概要
  • 創造的破壊の状況
  • 競争シナリオ

第13章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Akadeum Life Sciences
  • Becton, Dickinson and Co.
  • Bio-Rad Laboratories Inc.
  • Cell Microsystems Inc.
  • Danaher Corp.
  • General Electric Co.
  • Merck KGaA
  • Miltenyi Biotec BV & Co. KG
  • pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG
  • Thermo Fisher Scientific Inc.

第14章 付録

  • 調査方法
  • 略語のリスト
  • ベンダーの市場ポジショニングの定義

第15章 TECHNAVIOについて

図表

LIST OF EXHIBITS:

  • Exhibit 01: Vendor offerings
  • Exhibit 02: Global healthcare market
  • Exhibit 03: Segments of global healthcare market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: End-user - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by end-user
  • Exhibit 20: Academic institutions and research laboratories - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Academic institutions and research laboratories - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Pharmaceutical and biotechnology companies - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Pharmaceutical and biotechnology companies - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Hospitals and clinical testing laboratories - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 25: Hospitals and clinical testing laboratories - Year-over-year growth 2020-2024 (%)
  • Exhibit 26: Market opportunity by end-user
  • Exhibit 27: Customer landscape
  • Exhibit 28: Market share by geography 2019-2024 (%)
  • Exhibit 29: Geographic comparison
  • Exhibit 30: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 31: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 32: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 33: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 37: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 38: Key leading countries
  • Exhibit 39: Market opportunity
  • Exhibit 40: Impact of drivers and challenges
  • Exhibit 41: Vendor landscape
  • Exhibit 42: Landscape disruption
  • Exhibit 43: Vendors covered
  • Exhibit 44: Vendor classification
  • Exhibit 45: Market positioning of vendors
  • Exhibit 46: Akadeum Life Sciences - Vendor overview
  • Exhibit 47: Akadeum Life Sciences - Product segments
  • Exhibit 48: Akadeum Life Sciences - Organizational developments
  • Exhibit 49: Akadeum Life Sciences - Key offerings
  • Exhibit 50: Becton, Dickinson and Co. - Vendor overview
  • Exhibit 51: Becton, Dickinson and Co. - Business segments
  • Exhibit 52: Becton, Dickinson and Co. - Organizational developments
  • Exhibit 53: Becton, Dickinson and Co. - Geographic focus
  • Exhibit 54: Becton, Dickinson and Co. - Segment focus
  • Exhibit 55: Becton, Dickinson and Co. - Key offerings
  • Exhibit 56: Bio-Rad Laboratories Inc. - Vendor overview
  • Exhibit 57: Bio-Rad Laboratories Inc. - Business segments
  • Exhibit 58: Bio-Rad Laboratories Inc. - Organizational developments
  • Exhibit 59: Bio-Rad Laboratories Inc. - Geographic focus
  • Exhibit 60: Bio-Rad Laboratories Inc. - Segment focus
  • Exhibit 61: Bio-Rad Laboratories Inc. - Key offerings
  • Exhibit 62: Cell Microsystems Inc. - Vendor overview
  • Exhibit 63: Cell Microsystems Inc. - Product segments
  • Exhibit 64: Cell Microsystems Inc. - Organizational developments
  • Exhibit 65: Cell Microsystems Inc. - Key offerings
  • Exhibit 66: Danaher Corp. - Vendor overview
  • Exhibit 67: Danaher Corp. - Business segments
  • Exhibit 68: Danaher Corp. - Organizational developments
  • Exhibit 69: Danaher Corp. - Geographic focus
  • Exhibit 70: Danaher Corp. - Segment focus
  • Exhibit 71: Danaher Corp. - Key offerings
  • Exhibit 72: General Electric Co. - Vendor overview
  • Exhibit 73: General Electric Co. - Business segments
  • Exhibit 74: General Electric Co. - Organizational developments
  • Exhibit 75: General Electric Co. - Geographic focus
  • Exhibit 76: General Electric Co. - Segment focus
  • Exhibit 77: General Electric Co. - Key offerings
  • Exhibit 78: Merck KGaA - Vendor overview
  • Exhibit 79: Merck KGaA - Business segments
  • Exhibit 80: Merck KGaA - Organizational developments
  • Exhibit 81: Merck KGaA - Geographic focus
  • Exhibit 82: Merck KGaA - Segment focus
  • Exhibit 83: Merck KGaA - Key offerings
  • Exhibit 84: Miltenyi Biotec BV & Co. KG - Vendor overview
  • Exhibit 85: Miltenyi Biotec BV & Co. KG - Product segments
  • Exhibit 86: Miltenyi Biotec BV & Co. KG - Organizational developments
  • Exhibit 87: Miltenyi Biotec BV & Co. KG - Key offerings
  • Exhibit 88: pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG - Vendor overview
  • Exhibit 89: pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG - Product segments
  • Exhibit 90: pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG - Key offerings
  • Exhibit 91: Thermo Fisher Scientific Inc. - Vendor overview
  • Exhibit 92: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 93: Thermo Fisher Scientific Inc. - Organizational developments
  • Exhibit 94: Thermo Fisher Scientific Inc. - Geographic focus
  • Exhibit 95: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibit 96: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 97: Validation techniques employed for market sizing
  • Exhibit 98: Definition of market positioning of vendors
目次
Product Code: IRTNTR40160

About this market

Technavio's cell separation market analysis considers sales from academic institutions and research laboratories, pharmaceutical and biotechnology companies, and hospitals and clinical testing laboratories end-users. Our study also finds the sales of cell separation in Asia, Europe, North America, and ROW. In 2019, the academic institutions and research laboratories segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as demand for cell separation to carry out research studies related to cell enumeration and cell functional assays will play a significant role in the academic institutions and research laboratories segment to maintain its market position. Also, our global cell separation market report looks at factors such as growing adoption of cell separation techniques in research and clinical applications, increasing use of cell separation in cancer research, and high prevalence of HIV/AIDS. However, presence of inconsistent reagents and other ancillary products, exposure risks faced by laboratory personnel, and risk of sample contamination may hamper the growth of the cell separation industry over the forecast period.

Overview

Increasing use of cell separation in cancer research

Cell separation helps the identification and characterization of cancer stem cells. The analysis of single cancer cells by medical practitioners can aid in the early diagnosis of tumors, the monitoring of circulating tumor cells, and the evaluation of intratumor heterogeneity. It can also aid the determination of the need for chemotherapeutic treatments. Also, the incidence of cancer is increasing rapidly, especially amongst women. Cervical and breast cancers are the most common types in the world. The rising incidence of cancer is encouraging further research in the field. Moreover, advances in computer techniques, optics, and lasers introduced a new generation of cell separation techniques which are capable of high speed processing of single cell suspensions. This use of cell separation in cancer research will lead to the expansion of the global cell separation market at a CAGR of over 17% during the forecast period.

Growing focus on personalized medicine

The high number of adverse drug reactions, rising awareness about early diagnosis, and advancements in genetic science are driving the growth of personalized medicines. Genome mapping studies are crucial for the development of personalized medicines, and they could only be achieved if cell separation is performed adequately in studies and research projects. The focus on analyzing DNA synthesis is increasing during cell separation, which can be used for the development of personalized medicines against targets. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global cell separation market during the forecast period 2020-2024, view our report.

Competitive Landscape

With the presence of a few major players, the global cell separation market is highly concentrated. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading cell separation manufacturers, that include Akadeum Life Sciences, Becton, Dickinson and Co., Bio-Rad Laboratories Inc., Cell Microsystems Inc., Danaher Corp., General Electric Co., Merck KGaA, Miltenyi Biotec BV & Co. KG, pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG, and Thermo Fisher Scientific Inc.

Also, the cell separation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market outlook
  • Market size and forecast 2019-2024

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Academic institutions and research laboratories -
  • Market size and forecast 2019-2024
  • Pharmaceutical and biotechnology companies -
  • Market size and forecast 2019-2024
  • Hospitals and clinical testing laboratories -
  • Market size and forecast 2019-2024
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Increasing number of research activities related to stem cells
  • Growing focus on personalized medicine
  • Focus on promotional activities

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Akadeum Life Sciences
  • Becton, Dickinson and Co.
  • Bio-Rad Laboratories Inc.
  • Cell Microsystems Inc.
  • Danaher Corp.
  • General Electric Co.
  • Merck KGaA
  • Miltenyi Biotec BV & Co. KG
  • pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG
  • Thermo Fisher Scientific Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO